Exponential consensus ranking improves the outcome in docking and receptor ensemble docking
暂无分享,去创建一个
Claudio N. Cavasotto | Claudio N Cavasotto | Pilar Cossio | Isaias Lans | Karen Palacio-Rodríguez | C. Cavasotto | Pilar Cossio | Isaias Lans | Karen Palacio-Rodríguez
[1] Huikun Zhang,et al. Machine Learning Consensus Scoring Improves Performance Across Targets in Structure-Based Virtual Screening , 2017, J. Chem. Inf. Model..
[2] Marcin J. Skwark,et al. Improved Contact Predictions Using the Recognition of Protein Like Contact Patterns , 2014, PLoS Comput. Biol..
[3] Florence Demenais,et al. Association of Forced Vital Capacity with the Developmental Gene NCOR2 , 2016, PloS one.
[4] J. Irwin,et al. Benchmarking sets for molecular docking. , 2006, Journal of medicinal chemistry.
[5] A. Almeida,et al. Enhanced resistive switching characteristics in Pt/BaTiO3/ITO structures through insertion of HfO2:Al2O3 (HAO) dielectric thin layer , 2017, Scientific Reports.
[6] Shaomeng Wang,et al. How Does Consensus Scoring Work for Virtual Library Screening? An Idealized Computer Experiment , 2001, J. Chem. Inf. Comput. Sci..
[7] Salvatore Guccione,et al. In silico screening for human norovirus antivirals reveals a novel non-nucleoside inhibitor of the viral polymerase , 2018, Scientific Reports.
[8] D. Fairlie,et al. Comparing sixteen scoring functions for predicting biological activities of ligands for protein targets. , 2015, Journal of molecular graphics & modelling.
[9] F. Javier Luque,et al. Ligand-induced changes in the binding sites of proteins , 2002, Bioinform..
[10] J Andrew McCammon,et al. Target flexibility in molecular recognition. , 2005, Biochimica et biophysica acta.
[11] H. Wolfson,et al. Multiple diverse ligands binding at a single protein site : A matter of pre-existing populations , 2001 .
[12] Claudio N. Cavasotto,et al. Open challenges in structure-based virtual screening: Receptor modeling, target flexibility consideration and active site water molecules description. , 2015, Archives of biochemistry and biophysics.
[13] Danzhi Huang,et al. Hydrogen Bonding Penalty upon Ligand Binding , 2011, PloS one.
[14] Holger Gohlke,et al. Target flexibility: an emerging consideration in drug discovery and design. , 2008, Journal of medicinal chemistry.
[15] Woody Sherman,et al. Generation of Receptor Structural Ensembles for Virtual Screening Using Binding Site Shape Analysis and Clustering , 2012, Chemical biology & drug design.
[16] Claudio N. Cavasotto and Narender Singh. Docking and High Throughput Docking: Successes and the Challenge of Protein Flexibility , 2008 .
[17] Sheng-You Huang,et al. Exploring the potential of global protein-protein docking: an overview and critical assessment of current programs for automatic ab initio docking. , 2015, Drug discovery today.
[18] Jessica Holien,et al. Improvements, trends, and new ideas in molecular docking: 2012–2013 in review , 2015, Journal of molecular recognition : JMR.
[19] Ruben Abagyan,et al. ICM—A new method for protein modeling and design: Applications to docking and structure prediction from the distorted native conformation , 1994, J. Comput. Chem..
[20] S. Rasmussen,et al. Structure of a nanobody-stabilized active state of the β2 adrenoceptor , 2010, Nature.
[21] Zhihai Liu,et al. Comparative Assessment of Scoring Functions on a Diverse Test Set , 2009, J. Chem. Inf. Model..
[22] Claudio N. Cavasotto,et al. The Challenge of Considering Receptor Flexibility in Ligand Docking and Virtual Screening , 2005 .
[23] Matthieu Montes,et al. NRLiSt BDB, the manually curated nuclear receptors ligands and structures benchmarking database. , 2014, Journal of medicinal chemistry.
[24] Gisbert Schneider,et al. Automating drug discovery , 2017, Nature Reviews Drug Discovery.
[25] Claudio N. Cavasotto,et al. Ligand docking and structure-based virtual screening in drug discovery. , 2007, Current topics in medicinal chemistry.
[26] Santosh A. Khedkar,et al. Successful applications of computer aided drug discovery: moving drugs from concept to the clinic. , 2010, Current topics in medicinal chemistry.
[27] Yu-chian Chen. Beware of docking! , 2015, Trends in pharmacological sciences.
[28] António J. M. Ribeiro,et al. Protein-ligand docking in the new millennium--a retrospective of 10 years in the field. , 2013, Current medicinal chemistry.
[29] Claudio N. Cavasotto,et al. High-throughput and in silico screenings in drug discovery , 2009, Expert opinion on drug discovery.
[30] Shu Liu,et al. Application of Consensus Scoring and Principal Component Analysis for Virtual Screening against β-Secretase (BACE-1) , 2012, PloS one.
[31] Xiaoqin Zou,et al. Scoring functions and their evaluation methods for protein-ligand docking: recent advances and future directions. , 2010, Physical chemistry chemical physics : PCCP.
[32] Xavier Barril,et al. rDock: A Fast, Versatile and Open Source Program for Docking Ligands to Proteins and Nucleic Acids , 2014, PLoS Comput. Biol..
[33] Jan H. Jensen,et al. PROPKA3: Consistent Treatment of Internal and Surface Residues in Empirical pKa Predictions. , 2011, Journal of chemical theory and computation.
[34] David Ryan Koes,et al. Lessons Learned in Empirical Scoring with smina from the CSAR 2011 Benchmarking Exercise , 2013, J. Chem. Inf. Model..
[35] W. L. Jorgensen. The Many Roles of Computation in Drug Discovery , 2004, Science.
[36] Vincent B. Chen,et al. Correspondence e-mail: , 2000 .
[37] Michael M. Mysinger,et al. Directory of Useful Decoys, Enhanced (DUD-E): Better Ligands and Decoys for Better Benchmarking , 2012, Journal of medicinal chemistry.
[38] Shuichi Hirono,et al. Comparison of Consensus Scoring Strategies for Evaluating Computational Models of Protein-Ligand Complexes , 2006, J. Chem. Inf. Model..
[39] Noel M. O'Boyle,et al. De novo design of molecular wires with optimal properties for solar energy conversion , 2011, J. Cheminformatics.
[40] Jer-Wei Chang,et al. A Novel Histone Deacetylase Inhibitor Exhibits Antitumor Activity via Apoptosis Induction, F-Actin Disruption and Gene Acetylation in Lung Cancer , 2010, PloS one.
[41] Ruben Abagyan,et al. Recipes for the Selection of Experimental Protein Conformations for Virtual Screening , 2010, J. Chem. Inf. Model..
[42] N. Berry,et al. Targeting SxIP-EB1 interaction: An integrated approach to the discovery of small molecule modulators of dynamic binding sites , 2017, Scientific Reports.
[43] Cheng Zhang,et al. Structure and Function of an Irreversible Agonist-β2 Adrenoceptor complex , 2010, Nature.
[44] Chris Morley,et al. Open Babel: An open chemical toolbox , 2011, J. Cheminformatics.
[45] David S. Goodsell,et al. AutoDock4 and AutoDockTools4: Automated docking with selective receptor flexibility , 2009, J. Comput. Chem..
[46] X. Barril,et al. Unveiling the full potential of flexible receptor docking using multiple crystallographic structures. , 2005, Journal of medicinal chemistry.
[47] B. Shoichet,et al. Soft docking and multiple receptor conformations in virtual screening. , 2004, Journal of medicinal chemistry.
[48] Ajay N. Jain. Bias, reporting, and sharing: computational evaluations of docking methods , 2008, J. Comput. Aided Mol. Des..
[49] Claudio N. Cavasotto,et al. Representing receptor flexibility in ligand docking through relevant normal modes. , 2005, Journal of the American Chemical Society.
[50] Claudio N. Cavasotto,et al. Chapter 8:Binding Free Energy Calculation and Scoring in Small-Molecule Docking , 2012 .
[51] Tingjun Hou,et al. Assessing an Ensemble Docking-Based Virtual Screening Strategy for Kinase Targets by Considering Protein Flexibility , 2014, J. Chem. Inf. Model..
[52] N. Zhang,et al. Enriching screening libraries with bioactive fragment space. , 2016, Bioorganic & medicinal chemistry letters.
[53] J. Pin,et al. Virtual screening workflow development guided by the "receiver operating characteristic" curve approach. Application to high-throughput docking on metabotropic glutamate receptor subtype 4. , 2005, Journal of medicinal chemistry.
[54] Claudio N. Cavasotto,et al. Conformational Sampling of Protein Flexibility in Generalized Coordinates: Application to Ligand Docking , 2005 .
[55] Gisbert Schneider,et al. Computer-based de novo design of drug-like molecules , 2005, Nature Reviews Drug Discovery.
[56] Jan H. Jensen,et al. Improved Treatment of Ligands and Coupling Effects in Empirical Calculation and Rationalization of pKa Values. , 2011, Journal of chemical theory and computation.
[57] Claudio N. Cavasotto,et al. Ligand and Decoy Sets for Docking to G Protein-Coupled Receptors , 2012, J. Chem. Inf. Model..
[58] Claudio N. Cavasotto,et al. Protein flexibility in ligand docking and virtual screening to protein kinases. , 2004, Journal of molecular biology.
[59] Woody Sherman,et al. Exploring protein flexibility: incorporating structural ensembles from crystal structures and simulation into virtual screening protocols. , 2012, The journal of physical chemistry. B.
[60] Claudio N. Cavasotto,et al. Computational chemistry in drug lead discovery and design , 2018, International Journal of Quantum Chemistry.
[61] Max W. Chang,et al. Virtual Screening for HIV Protease Inhibitors: A Comparison of AutoDock 4 and Vina , 2010, PloS one.
[62] William L Jorgensen,et al. Efficient drug lead discovery and optimization. , 2009, Accounts of chemical research.
[63] Didier Rognan,et al. The impact of in silico screening in the discovery of novel and safer drug candidates. , 2017, Pharmacology & therapeutics.
[64] Weiliang Zhu,et al. Molecular docking for drug discovery and development: a widely used approach but far from perfect. , 2016, Future medicinal chemistry.
[65] Dariusz Plewczynski,et al. VoteDock: Consensus docking method for prediction of protein–ligand interactions , 2011, J. Comput. Chem..
[66] Claudio N. Cavasotto,et al. In silico drug discovery and design : theory, methods, challenges, and applications , 2015 .
[67] Hwangseo Park,et al. Consensus Scoring Approach To Identify the Inhibitors of AMP-Activated Protein Kinase α2 with Virtual Screening , 2014, J. Chem. Inf. Model..
[68] Bin Liu,et al. Novel Consensus Docking Strategy to Improve Ligand Pose Prediction , 2018, J. Chem. Inf. Model..
[69] Tiziano Tuccinardi,et al. Extensive Consensus Docking Evaluation for Ligand Pose Prediction and Virtual Screening Studies , 2014, J. Chem. Inf. Model..
[70] Heather A Carlson,et al. Protein flexibility is an important component of structure-based drug discovery. , 2002, Current pharmaceutical design.
[71] A. Kukol. Consensus virtual screening approaches to predict protein ligands. , 2011, European journal of medicinal chemistry.
[72] M. Murcko,et al. Consensus scoring: A method for obtaining improved hit rates from docking databases of three-dimensional structures into proteins. , 1999, Journal of medicinal chemistry.
[73] Ching-Feng Weng,et al. Prediction of N-Methyl-D-Aspartate Receptor GluN1-Ligand Binding Affinity by a Novel SVM-Pose/SVM-Score Combinatorial Ensemble Docking Scheme , 2017, Scientific Reports.
[74] Abdulilah Ece,et al. The discovery of potential cyclin A/CDK2 inhibitors: a combination of 3D QSAR pharmacophore modeling, virtual screening, and molecular docking studies , 2013, Medicinal Chemistry Research.
[75] Arthur J. Olson,et al. AutoDock Vina: Improving the speed and accuracy of docking with a new scoring function, efficient optimization, and multithreading , 2009, J. Comput. Chem..
[76] Rodrigo Quiroga,et al. Vinardo: A Scoring Function Based on Autodock Vina Improves Scoring, Docking, and Virtual Screening , 2016, PloS one.